Companies similar to KYVERNA THERAPEUTICS INC (KYTX)
Health Care · NASDAQ
KYVERNA THERAPEUTICS INC (KYTX)'s closest peers include Bristol Myers Squibb (BMY), NOVARTIS AG (NVS), Gilead Sciences (GILD), BEAM THERAPEUTICS INC (BEAM) and INTELLIA THERAPEUTICS INC (NTLA). This peer set is drawn from KYTX's enriched company profile and is informational only — not financial advice.
Similar companies
-
Bristol Myers SquibbBMYHealth Care
Bristol Myers Squibb is a leading biopharmaceutical company specializing in advanced oncology, immunology, and cardiovascular therapies using diverse…
$60.93 (as of 2026-07-21) · market cap $123.2B
-
NOVARTIS AGNVS
Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases.
$153.87 (as of 2026-07-21) · market cap $228.2B
-
Gilead SciencesGILDHealth Care
A diversified biopharmaceutical company pioneering viral disease treatments, cell therapies, and oncology medicines with a portfolio spanning HIV, hepatitis,…
$130.28 (as of 2026-07-21) · market cap $161.3B
-
BEAM THERAPEUTICS INCBEAMHealth Care
Beam Therapeutics is developing base editing medicines—a precision genetic cure approach—for serious inherited diseases like sickle cell disease and rare…
$27.29 (as of 2026-07-21) · market cap $2.8B
-
INTELLIA THERAPEUTICS INCNTLAHealth Care
CRISPR-based genome editing company developing in vivo therapies for rare genetic diseases including hereditary angioedema and ATTR amyloidosis.
$11.47 (as of 2026-07-21) · market cap $1.6B
Not quite? Describe exactly what you want →
Peers are drawn from KYTX's enriched profile (the same similarity signal the chat uses for "companies like KYTX"). See the full profile: KYVERNA THERAPEUTICS INC (KYTX).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.